View
512
Download
5
Embed Size (px)
Citation preview
552
(BMD)
()
(WHO) BMD < 2.5 (25) T (T score)
(>75) ( 12) (GIOGIOP)
Genant
(Bone Mineral Density)
T score T < -2.5
-2.5 < T < -1
p 25
From Canalis et al, NEJM, 357: 905-916, 2007
From Canalis et al, NEJM, 357: 905-916, 2007
(1)
D
()
(2) () (Marfans syndrome)
( Ehlers-Danlos syndrome) (homocystinuria)
BMD (BMD)
Glucocorticoid-induced osteoporosis
Calcitonin Fluoride Strontium Thiazide Selective estrogen receptor
modulator (SERM) Bisphosphonate Salt restriction
D :
Actonel (Ladogal, danazol) (Livial, tibolone) (SERM): (Evista, raloxifene) D: () (onealfa) : (Forteo, teriparatide) : (Prolia, denosumab) (Miacalcic) :
(ONJosteonecrosisofthejaw)
Teriparatide
(3%), (3%) (8%), (4%), (4%) (5%) (4-6 11% 6%) (9%), (5%), (3%), (2%)
(3%) (10%), (9%), (3%),
(10%), (6%), (4%), (4%)
: ( 3%), (?)
Prolia
Prolia (34.7%) (11.7%)
(7.6%) (7.2%) (5.9%) (osteonecrosis of the jaw, ONJ)
Vertebroplasty
Morphopedics
Baloon Kyphoplasty
(!!)
()
D K &
D
D () 10-15 D
K
p K D ::
C
p C ::
&
p D : 5 5060
() 10 (240cc/) 7
http://www.shef.ac.uk/FRAX/tool.jsp?lang=cht